The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Related Posts
Auto & Transport Roundup: Market Talk
Find insight on XPeng, Rheinmetall, Qantas, Volvo and more in the latest Market Talks covering the auto and transport sector.
Elon Musk’s $46 Billion Pay Package: How Tesla Shareholder Approval Could Play Out in Court
- staff
- June 13, 2024
- 0
The carmaker’s CEO says so far, shareholders were approving the package by a wide margin. But a vote to reapprove the agreement is unlikely to […]
Japan Gears Up for More Than $3 Billion of IPOs in October
Two Japanese companies will soon start testing investors’ appetite for their shares, with one of the listings likely to be the country’s largest this year.